Active implantable medical devices (AIMDs) is one of the most dynamic sectors in the healthcare industry today. AMIDs are powered devices that are partially or totally implanted into a patient’s body, either by surgical means or through a natural orifice. These devices are intended to remain in the patient’s body after the procedure. As these devices are intended to continue in direct contact with the patient’s body for long periods, they are subject to rigorous requirements and standards to protect the safety and health of patients.
The North American active implantable medical devices market is presently being driven by several driving factors. Both the United States and Canada are dominating the market in the NA region. The demand for active implantable medical devices is rising in NA region is owing to the growing incidences of cardiovascular diseases and rising occurrences of neurological disorders. Well-established healthcare industry across the region, rapid growth in the medical devices industry as well as rising exports of medical devices, increasing expenditure on healthcare industry, and ongoing investment by the public as well as private companies on the research and development activities are further likely to propel growth of the market in NA region.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the active implantable medical devices market. In addition, complete analysis of changes on active implantable medical devices market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on regional economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The study analyses North America active implantable medical devices market based on product, end-users and geography.
Active implantable medical devices market by product is segmented into implantable cardioverter defibrillators, ventricular assist devices, implantable heart monitors/insertable loop recorders, neurostimulators, and implantable hearing devices. The implantable cardioverter defibrillators segment is further bifurcated into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. Furthermore, neurostimulators segment is further segmented into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric electrical stimulators. And implantable hearing devices are categorized into active hearing implants and non-active/passive hearing implants.
The implantable cardioverter defibrillators segment is projected to witness high growth during the estimated timeframe. Cardiovascular disease is one of the major cause of death in the NA region. Implantable cardioverter defibrillators are the primary active medical devices used for the treatment of a variety of cardiovascular diseases. The high prevalence of cardiovascular diseases represents improved demand for these devices in the market. This is in turn impelling the segment growth.
By end users, the market is segmented into hospitals, ambulatory centers, cardiac centers, dental clinics, and others. Hospitals segment is anticipated to observe lucrative growth opportunities in the coming years. A growing number of acquisitions and mergers of hospitals and hospital systems, increased use of highly developed diagnostic products in the hospitals, and escalating demand for premature diagnosis and intervention are some of the key driving factors behind the growth of this segment.
Country wise, the study is comprised of the key countries such as the United States, Canada and Mexico. The United States held the largest market share of North America active implantable medical devices market and is likely to dominate the market over the estimated time frame. The presence of major market players such as Abbott Laboratories, Boston Scientific Corporation and many others is primary factor that attributed to the growth in the country.
In addition, factors such as rapid growth in the country’s medical devices industry, vast presence of medical devices manufacturers, growing occurrence rate of cardiovascular diseases such as heart attack, CAD, and many others, and surged demand to prevent death from these diseases are anticipated to improve market growth in the country.
The major key players of market includes Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co., Ltd, Zimmer Biomet, Smith & Nephew, Straumann AG, Stryker, Dentsply Sirona, Allergan Inc, Microport Scientific Corporation and CONMED Corporation among others.
The study analyses North America active implantable medical devices market based on product, end-users, and geography. Active implantable medical devices market by product is segmented into implantable cardioverter defibrillators, ventricular assist devices, implantable heart monitors/insertable loop recorders, neurostimulators, and implantable hearing devices. The implantable cardioverter defibrillators segment is likely to dominate the market over the forecast period. Increased prevalence rate of cardiovascular diseases across the region is attributed to the market growth. By end users, the market is segmented into hospitals, ambulatory centers, cardiac centers, dental clinics, and others. The hospitals segment is likely to register fastest growth in years to come owing to the increasing number of hospitals across the region. Geographically, the study is comprised of the key countries such as the United States, Canada and Mexico.
Why to buy this report: